• Profile

A TRP family based signature for prognosis prediction in head and neck squamous cell carcinoma

Journal of Oncology Feb 02, 2022

A robust risk signature based on transient receptor potential family genes (TFGs) for prognosis evaluation in head and neck squamous cell carcinoma (HNSCC) was developed, and the TFGs-based signature (TFBS) proposed herein could be a favorable indicator to predict the survival outcome in HNSCC and provides prominent treatment guidance.

  • Using HNSCC sample data from the TCGA website, experts integrated expression profiles of TFGs for 490 HNSCC cases.

  • Screening of 6 TFGs (TRPC1, TRPC3, TRPC6, TRPV2, TRPV4, and TRPM8) closely linked with prognosis of HNSCC cases was conducted to construct TFBS.

  • A dismal patient outcome in the TFBS-high group was predicted by TFBS.

  • On Cox regression, favorable independent value of TFBS was evident.

  • In receiver operating characteristic analysis, TFBS demonstrated robust power for predicting prognosis.

  • In gene set enrichment analysis, various important pathways associated with HNSCC were unveiled, including the p53 pathway, TNF-alpha signaling via NFKB, and hypoxia.

  • Patients in the TFBS-high group were more likely in immunosuppressive status.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen